| 摘要 |
The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, specifically malignant melanoma. The invention discloses peptides derived from one or more presently unidentified genes, as well as variants of these proteins that can be used to stimulate a CTL response against melanoma. Further disclosed, is a peptide derived from gp100, which can also be used to stimulate a CTL response against melanoma. |
